机构：[1]The 4nd Hospital, Hebei Medical University, Shijiazhuang, China, the People's Republic,[2]Research Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China, the People's Republic, 河北医科大学第四医院科研中心医技科室[3]Clinical Laboratory, Bethune International Peace Hospital, Shijiazhuang, China, the People's Republic
第一作者机构：[1]The 4nd Hospital, Hebei Medical University, Shijiazhuang, China, the People's Republic,
推荐引用方式(GB/T 7714)：
Ma M.,Zhao L.,Zhang J.,et al.MiR-429 enhances sensitivity of Burkitt lymphoma cells to chemotherapy drugs via targeting Bmi-1[J].EUROPEAN JOURNAL OF IMMUNOLOGY.2019,49:631-631.
APA：
Ma, M.,Zhao, L.,Zhang, J.,Chen, J.&Shan, B..(2019).MiR-429 enhances sensitivity of Burkitt lymphoma cells to chemotherapy drugs via targeting Bmi-1.EUROPEAN JOURNAL OF IMMUNOLOGY,49,
MLA：
Ma, M.,et al."MiR-429 enhances sensitivity of Burkitt lymphoma cells to chemotherapy drugs via targeting Bmi-1".EUROPEAN JOURNAL OF IMMUNOLOGY 49.(2019):631-631
